glp-1 news employers Some US to drop coverage of obesity drugs in 2027 as use increases MedCity Pivot Podcast: Self-insured Employers

Actionable Next Steps For those intrigued by the potential of NAD+ and AOD9604: Educate Yourself: Continue to research these compounds through reputable scientific sources

Current evidence regarding toxicity from GHK-Cu is limited, but factors such as product concentration, frequency of use, and underlying health conditions (like Wilson's disease) may influence risk considerations

Zatonski, MD, PhD is a double board-certified physician, author, husband, and parent

Boost energy and combat fatigue [1] Reduce stress levels [2] Enhance mood and mental well-being [3] Sharpen focus and reduce brain fog [4] Young LM, Pipingas A, White DJ, Gauci S, Scholey A

First axis, copper chelation and transport

Tirzepatide is a dual-action GLP-1/GIP agonist that works by mimicking your bodys natural hormones, helping you feel fuller faster and for longer